Abstract
PREVIEWChoosing appropriate antimicrobial therapy is no longer a simple process. Even for the common problems of respiratory tract disease in children and adults, selection is complicated by both increasing microbial resistance and the daunting number of extended-spectrum antibiotics now on the market. In this article, Drs Singh and Arrieta look at the problem from all aspects and give their specific recommendations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have